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In the MUSE classification ofgastroesophageal reflux disease (GERD), esophagitis is assessed by
thepresence ofmetaplasia, ulcer, stricture, orerosion, each being gradedas absent, mildor severe.
Daily reflux symptoms affect about 4 to 7percent ofthe population; erosive esophagitis occurs in
about 2percent; theprevalence rate ofBarrett's metaplasia is 0.4percent; and esophageal adeno-
carcinoma leads to two deaths per million living population. In persons with GERD symptoms,
about 20percent arefound to have erosive esophagitis, while ulcers or strictures arefound in less
than 5 percent ofall patients with erosive esophagitis. No clear-cut temporal progression exists
between successive grades ofdisease severity, as the most severe grade ofGERD is reached at the
onsetofthe disease. Mildforms ofGERD tendto be more common in women than men, while severe
GERD characterized by erosive esophagitis, esophageal ulcer, stricture orBarrett's metaplasia are
far more common in men than women. All forms of GERD affect Caucasians more often than
African Americans orNative Americans. Theprevalence ofGERD is high among developed coun-
tries in North America and Europe and relatively low in developing countries in Africa andAsia.
During the past three decades, hospital discharges and mortality rates ofgastric cancer, gastric
ulcer and duodenal ulcer have declined, while those ofesophageal adenocarcinoma and GERD
have markedly risen. These opposing time trends suggest that corpus gastritis secondary to
Helicobacter pylori infection protects against GERD. This hypothesis is consistent with the geo-
graphic and ethnic distributions ofGERD. Case-control studies also indicate that cases with ero-
sive esophagitis are less likely to harbor active or chronic corpus gastritis than controls without
esophagitis.
INTRODUCTION
The general epidemiology of gastroe-
sophageal reflux disease (GERD)b was
presented in several previous articles [1-
3]. Rather than provide another compre-
hensive review ofGERD epidemiology, in
the present article we will discuss primar-
ily its clinical epidemiology and natural
history and focus attention on recent
developments in these two areas. New data
are emerging to suggest that, besides pep-
tic ulcer and gastric cancer, gastrointesti-
nal infection withHelicobacterpylori may
also explain several characteristic features
of GERD epidemiology. We conclude by
listing the many remaining open questions
of GERD.
a To whom all correspondence should be addressed: Amnon Sonnenberg, M.D., M.Sc.,
Department of Veterans Affairs Medical Center 1 1 1-F, 1501 San Pedro Drive SE,
Albuquerque, NM 87108. Tel.: 505-265-171 1; Fax: 505-256-5751;
E-mail: sonnbrg@unm.edu.
b Abbreviations: GERD, gastroesophageal reflux disease; NSAIDs, non-steroidal anti-
inflammatory drugs.
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CLINICAL EPIDEMIOLOGY
Clinicalpresentation
The term gastroesophageal reflux dis-
ease (GERD) is used to describe the symp-
toms and changes of the esophageal
mucosa that result from reflux of stomach
contents into the esophagus. GERD
patients present with symptoms ofepigas-
tric pain, heartburn, pharyngeal burning,
regurgitation of gastric contents, acidic
taste and dysphagia. Such symptoms may
be experienced daily, weekly or only few
times per month. With respect to GERD,
individual symptoms carry a sensitivity or
specificity that, in general, do not exceed
65 percent or 80 percent, respectively [4].
The frequency and severity of symptoms
from gastroesophageal reflux do not corre-
late with the amount of morphologic
changes of the mucosa seen on endoscop-
ic examination of the esophagus.
Most commonly used grading sys-
tems of GERD are based on the Savary-
Miller classification [5]. Subjects with
reflux symptoms but no macroscopically
visible lesions are said to have reflux dis-
ease without esophagitis, sometimes
referred to as "grade 0." Peptic esophagitis
is graded according to the extent and
severity of macroscopically visible ero-
sions: single patchy, large confluent orcir-
cumferential erosions representing grade I,
II, or III, respectively. The terms "compli-
cated esophagitis" or "grade IV" relate to
esophagitis accompanied by Barrett's
mucosa, ulcers or strictures. The syn-
onyms "Barrett's esophagus," "epitheli-
um" or "metaplasia" refer to the replace-
ment of esophageal squamous epithelium
by a gastric type of columnar epithelium
with (or without) intestinal metaplasia that
reaches 2 to 3 cm above the lower
esophageal sphincter. Barrett's epithelium
is more susceptible than the regular squa-
mous epithelium of the esophagus to the
development ofdeep ulcers that reach into
the submucosa. In a minority of patients,
healing of erosions or ulcers results in
scarring and formation of a peptic stric-
ture.
The Savary-Miller classification of
GERD puts much emphasis on various
types of erosions, but lumps esophageal
metaplasia, ulcers and strictures into one
grade. Moreover, it does not account for
the frequent concurrence of Barrett's
epithelium with stricture or stricture with
erosions. The newer, more refined, MUSE
classification grades esophagitis according
to presence of metaplasia, ulcer, stricture
or erosion, each being assigned a value
ranging from 0 to 2, that is, absent, mild or
severe, respectively [5].
Barrett's epithelium is considered a
premalignant lesion, as the incidence rate
ofesophageal adenocarcinoma developing
from Barrett's mucosa is 1 percent per
year [6]. In the International Classification
of Diseases, esophageal adenocarcinoma
is listed as "cardiac cancer." The demo-
graphic characteristics and time trends of
esophageal adenocarcinoma (or cancer of
the gastric cardia) are very similar to those
of GERD. They are strikingly different
from those of adenocarcinoma in the gas-
tric body and antrum or squamous carci-
noma of the esophagus. Despite these
obvious similarities and its origin from
Barrett's metaplasia, however, esophageal
adenocarcinoma is not included in the
classification ofesophagitis.
Prevalence rates
Daily reflux symptoms affect about 4
to 7 percent of the population, while
esophageal adenocarcinoma leads to 2.5
deaths per million living population [2-3].
The prevalence rates ofthe other presenta-
tions ofreflux disease in the middle range
between these two extremes are far less
well characterized. A recent study from
China estimated a 5 percent prevalence
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presenting with symptoms suggestive of
GERD, 18.5 percent were found to have
erosive esophagitis. A Swedish study
reported an incidence rate of 120 new
cases of erosive esophagitis per 100,000
per year [8]. Assuming a case history of20
years yields a crude estimate 2.4 percent
for the prevalence rate. Ulcers or strictures
were found in less than 5 percent of all
patients with erosive esophagitis. Lastly, a
post-mortem study from Olmsted County
in Minnesota found a prevalence rate of
0.4 percent for Barrett's esophagus [9].
Since symptoms are a poor indicators
for disease severity, a study trying to
assess the true prevalence of erosive
esophagitis and its complications would
need to subject a large group ofpersons to
upper gastrointestinal endoscopy. For
obvious reasons, such a study is difficult
and expensive to conduct. Because symp-
tomatic patients are more likely to under-
go endoscopy, incidence and prevalence
rates based largely on routine endoscopy
reports may overestimate the prevalence
rate of erosive esophagitis in the general
population. The prevalence of GERD
varies markedly between different popula-
tions [1, 10]. During the past three decades
the prevalence of GERD has increased
more than two-fold, and previously report-
ed data may no longer apply to present day
populations [3]. With all these caveats in
mind, one should consider the data cited
above as crude estimates only.
Diseases associated with GERD
Esophageal clearance is markedly
impaired in CRST syndrome and systemic
sclerosis because muscle atrophy results in
dysfunction of the lower sphincter and
aperistalsis of the tubular esophagus [11-
15]. Among the population of U.S. mili-
tary veterans, we found systemic sclerosis
to be associated with a six-fold increased
risk for erosive esophagitis [16]. In
Sjogren's syndrome, reduced or absent
salivary secretion interferes with normal
esophageal clearance and also results in an
increased risk for erosive esophagitis [15].
Presently, there are no risk factors
known to disrupt tissue resistance, except
for non-steroidal anti-inflammatory drugs
(NSAIDs). Several authors have suggested
that more severe forms ofpeptic esophagi-
tis, associated with large confluent ero-
sions, strictures and Barrett's esophagus,
are more common in patients on chronic
consumption of NSAIDs [16-18]. In the
population of veterans, many of the dis-
eases commonly treated with NSAIDs,
such as osteoarthritis, back pain or tension
headache, were associated with a small but
nevertheless significant odds ratio ofabout
1.4 for reflux esophagitis [16].
Frequent occurrence of nighttime
reflux can irritate the pharyngeal and
laryngeal structures and result in laryngitis
or even hoarseness and aphonia.
Aspiration of gastric contents has been
associated with asthma, pneumonia, and
bronchiectasies [19-21]. In our epidemio-
logical study of GERD among U.S. mili-
tary veterans, we found both erosive
esophagitis and esophageal stricture to be
significantly associated with sinusitis,
aphonia, pharyngitis, laryngeal stenosis,
laryngitis, chronic bronchitis, asthma,
chronic obstructive pulmonary disease,
pulmonary fibrosis, bronchiectasis, pul-
monary collapse and pneumonia [21].
While the odds ratios for sinus, laryngeal
and pharyngeal diseases ranged between
1.5 and 2.0, the odds ratios for the associ-
ation between GERD and pulmonary dis-
ease did not exceed 1.5. This may reflect,
in part, the a high overall prevalence of
respiratory disease in the population of
veterans.
Except for the striking example of
Zollinger-Ellison syndrome, the associa-
tion between the amount of acid output
and the occurrence or severity of reflux
disease has remained elusive [22-24].
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between the amount of acid reflux and the
occurrence of Barrett's esophagus, as well
as, with its length above the lower
esophageal sphincter [25-26]. Several
authors have also reported a coincidence
ofduodenal ulcers and erosive esophagitis
in patients without Zollinger-Ellison syn-
drome [27]. Both endoscopy and, to a less-
er extent, barium swallow are primary
modalities to diagnose reflux esophagitis,
as well as peptic ulcer. This makes it diffi-
cult to discern a true association from an
association brought forth by a detection
bias.
NATURAL HISTORY
Initially, it was thought that in the nat-
ural history of the disease, mild forms of
GERD progressed to more severe forms.
This concept led to the original Savary and
Miller classification of GERD by grades
of severity [1]. Physicians were advised to
prevent the more severe grades of GERD
involving Barrett's mucosa or strictures by
early and vigorous treatment of mild
forms, such as single erosions or even
reflux symptoms only.
On one hand, epidemiologic studies
show that hiatus hernia is frequently found
in patients with GERD and that all forms
of GERD tend to cluster in the same
patient population [1-3]. In our study of
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Figure 1. Co-morbid associations between four forms of GERD, each arrow repre-
senting one association. The percentage describes the fraction of patients with one form
of GERD (where the arrow starts) who also suffer from a second form (to which the arrow
points). The circular arrows represent patients who have one form of GERD as their sole
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Figure 2. Relationship between disease severity and length of GERD history. Figure
adapted from [1].
form of GERD was 10-times more likely
to occur in a patient with another form of
GERD than without, the highest ratio (R =
22) found among esophageal ulcers and
stricture [28]. About one-third of all
patients with esophageal erosions, ulcers
or strictures also had hiatus hernia, and 46
percent of patients a hiatus hernia were
diagnosed to have other forms of GERD.
While hiatus hernia or erosive esophagitis
represented the only diagnosis related to
GERD in half of the patients, strictures
rarely and esophageal ulcers never
occurred alone. This pattern leads one to
believe that in a fraction of GERD
patients' esophageal erosions may result in
scarring or progress to deeper ulcerations
(Figure 1). The clustering of different
forms of damage to the esophageal
mucosa in identical patients clearly points
at a close patho-physiologic relationship
among them. The more frequent occur-
rence of mild forms and the less frequent
occurrence of severe forms of GERD also
suggests that the present grading system
truly reflects consecutive stages of
increasing pathophysiologic derangement.
On the other hand, the same study
failed to show aclear-cut temporal relation-
ship between various forms ofGERD [28].
In few relationships, it appeared as if less
severe forms preceded the more severe
ones. For example, hiatus hernia tended to
precede esophageal erosions or ulcers.
Similarly, esophagitis was diagnosed
slightly more often before esophageal stric-
tures. However, appreciable numbers of
severe and mild forms of GERD presented
simultaneously or with the severe form
before the mild one. For example, in the
comorbid occurrence of esophagitis,
esophageal ulcer represented the initial
diagnosis in 39 percent, whereas esophagi-
tis represented the initial diagnosis in only
22 percent. Overall, no consistent progres-
sion from mild to severe forms of GERD
could appreciated. Onepossibility torecon-
cile the seeming contradiction between the
lackofprogression andthepatterns ofclus-
tering (described intheprevious paragraph)
is to assume that most progression between
different grades of severity occurs quite
rapidly. Thus, it would appear thatthe most
severe grade of GERD is reached at the
very onset of the disease. After this initial86 Sonnenberg and El-Serag: GERD epidemiology
rapid progression, little, if any, further
development is noticed subsequently. Inthe
individual patient, the presentation of
GERD and its severity of mucosal damage
seem to remain stationary or fluctuate only
between close grades of severity. This con-
tention is corroborated by other studies that
failed to establish a relationship between
the length ofcase history anddisease sever-
ity (Figure 2) [1].
In a subsequent study, we selected
29,500 patients with erosive esophagitis,
but without ulcers or strictures from the
population of veterans and followed them
over a four-year time period (range 1 to 12
years). Amazingly, not one of these
patients was subsequently diagnosed to
have developed such complications [29].
This was in striking contrast with a com-
parison group of 5,100 esophagitis
patients who presented initially with
esophageal ulcers or strictures. During fol-
low-up, about 80 percent of these patients





Mild forms of GERD tend to be
slightly more common in women than
men, while severe GERD characterized by
erosive esophagitis, esophageal ulcer or
stricture are far more common in men than
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Figure 3. Prevalence rates of various grades of acute (left panel) or chronic gastritis
(right panel) of the gastric body in 116 case subjects with and in 148 control sub-
jects without erosive esophagitis. The differences in the prevalence rates of acute and
chronic gastritis among case and control subjects were both statistically significant (df = 2,
c2 = 6.52, p = 0.0013 and df = 2, c2 = 8.92, p = 0.001 1 for the left and right panel, respec-
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women [2]. All forms of GERD affect
Caucasians more often than African
Americans or Native Americans. Similar
patterns characterize the epidemiology of
GERD and esophageal adenocarcinoma
[30]. In the United States, such variations
by gender and ethnicity are revealed simi-
larly by different types of epidemiologic
parameters, that is, prevalence data, physi-
cian visits, hospitalizations and death
rates. The prevalence of GERD is high
among residents of developed countries in
North America and Europe, but relatively
low among those of developing countries
in Africa and Asia [1, 10].
Between 1970 and 1987, the rates of
hospitalizations in the National Hospital
Discharge Survey, secondary to erosive
esophagitis, rose two-fold in men and
women alike [2]. A less striking increase
also occurred with respect to esophageal
stricture. The rise in hospitalization for
esophagitis was not matched by an equal
rise in surgical procedures, as the rate of
surgical repair of hiatal hernia declined
during the identical time period. The time
trends from the National Hospital
Discharge Survey are corroborated by
similar trends of hospitalizations among
U.S. military veterans and U.S. mortality
rates taken from the Vital Statistics of the
United States [31].
In the population of veterans, as in
many other populations, gastric and duo-
denal ulcer showed a significant decline of
their hospitalization rates between 1970
and 1995, the decline being more pro-
nounced in duodenal than gastric ulcer.
The hospitalization rates for gastric and
duodenal ulcer were similar among whites
and nonwhites. In striking contrast with
the behavior of peptic ulcer, the hospital
discharges involving GERD rose four- and
seven-fold among nonwhites and whites,
respectively, during the same time period.
While hospitalization resulting from can-
cer of the gastric corpus and antrum
declinedbetween 1968 and 1992, hospital-
ization from esophageal adenocarcinoma
increased during the same time period.
The time trends of mortality from gastric
ulcer, duodenal ulcer, gastric cancer and
esophageal adenocarcinoma provide an
almost exact replica of the corresponding
patterns in the hospitalization data.
ROLE OF H. PYLORI IN GERD
Because H. pylori plays an essential
role in the pathogenesis of gastric ulcer,
duodenal ulcer and gastric cancer, the gen-
eral decline ofits infection rate in Western
societies provides the most likely explana-
tion for the time trends of these three dis-
eases. The acquisition of H. pylori results
in the development of acute gastritis that,
if left untreated, gives way to chronic gas-
troduodenitis [32]. Both types of peptic
ulcer and gastric cancer are strongly corre-
lated with a gastroduodenal infection by
H. pylori [33-34]. Antral gastritis found
mostly in patients with duodenal ulcer,
leaves the ability to secrete acid unaffected
or even increases gastric acid output by
compromising somatostatin secretion of
the D-cells and its inhibitory effect on gas-
trin output. In contradistinction with antral
gastritis, gastritis that involves large areas
of the gastric body (corpus) results in par-
tial atrophy of the acid secreting mucosa
and hypochlorhydria [35-36]. In general,
patients with an endoscopically diagnosed
reflux esophagitis are less likely to harbor
active or chronic corpus gastritis than
patients without esophagitis [37-39].
Figure 3 shows data from our own series
of consecutive patients undergoing esoph-
agogastroduodenoscopy for various upper
gastrointestinal symptoms [39]. The
patient population comprised of 116 case
subjects with and 148 control subjects
without erosive esophagitis. The severity
of acute or chronic gastritis in the gastric
body, characterized bypolymorphonuclear
cells and lymphocytes, respectively, were88 Sonnenberg and El-Serag: GERD Epidemiology
DUT




corpus - acid <
GERDV
Figure 4. Scheme of the interaction between H. pylori infection, acid secretion and
disease outcome.
both inversely related to the prevalence
rate of erosive esophagitis. Overall,
patients with erosive esophagitis showed a
significantly lower prevalence rate of gas-
tritis in the body oftheir stomach. In some
patients, the hypochlorhydria secondary to
corpus gastritis becomes reversible once
the infection with H. pylori has been treat-
ed with antibiotics [35-36]. Labenz et al.
followed patients with duodenal ulcer after
antibiotic cure of H. pylori infection for
three years [40]. The incidence of reflux
esophagitis was 25.8 percent after eradica-
tion ofH. pylori compared to 12.9 percent
in patients with persistent infection.
Besides being responsible for the decline
of peptic ulcer and gastric cancer, there-
fore, the time trends H. pylori infection
also offer a possible explanation for the
rise of GERD and esophageal adenocarci-
noma. The opposing time trends of peptic
ulcer and gastric cancer on one side versus
GERD and esophageal adenocarcinoma
on the other side suggest that H. pylori
infection may protect against GERD.
An additional piece of evidence to
support the role of H. pylori in GERD is
provided by the remarkable differences
among ethnic groups. While U.S. non-
whites incurred substantially reduced hos-
pitalizations and mortality related to
GERD or esophageal adenocarcinoma,
they suffered more from gastric cancer
than whites [31]. In general, nonwhites in
the United States tend to harbor higher
rates of infection with H. pylori acquired
at a younger age than whites [41]. Again,
this pattern translates into prolonged time
periods of chronic gastritis and a greater
chance of developing mucosal atrophy of
the gastric body associated with reduced
acid output. Gastric atrophy and reduced
acid output mean a greater risk for gastric
cancer and a smaller risk for GERD and
esophageal adenocarcinoma, respectively.
The geographic distribution of GERD
could also relate to the geographic distrib-
ution of H. pylori. In developed countries
the decline in H. pylori infection is likely
to have resulted in an increases suscepti-
bility to develop GERD.
OPEN QUESTIONS
Figure 4 illustrates a working model
for the relationship between the infection
with H. pylori, its influence on acid secre-
tion and the occurrence ofvarious diseases
of the upper gastrointestinal tract. Despite
the strong and multifaceted evidence in
favor of H. pylori playing an important
role in the epidemiology of GERD, many
issues still remain unresolved. Itis present-
ly unclear why some types ofinfection are
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while others involve the whole stomach. It
was hypothesized that childhood infection
versus infection during adolescence or
adulthood may, in part, determine the out-
come ofgastritis [42]. As indicated by this
scheme, H. pylori infection may exert two
diametrically opposite influences on the
upper gastrointestinal tract, one associated
with an increased and the other with a
decreased risk for GERD. Simple case-
control studies trying to associate H. pylori
infection with GERD will not be able to
resolve this mystery. Vicari et al., for
instance, found that the occurrence of H.
pylori infection was lower in 153 GERD
patients than in 57 controls, that is 34 per-
cent versus 46 percent, but this difference
failed to reach statistical significance [43].
The severity, spread and type of gastritis,
the immune response by the host and the
genetic make-up ofthe organism may ulti-
mately determine amount of acid output
and its influence on reflux disease [43-44].
The second open question concerns
the role ofgastric acid secretion in GERD.
On one hand, vigorous inhibition of gas-
tric acid secretion constitutes the most
efficacious means to treat GERD.
Moreover, the exposure time of the
esophageal mucosa to pH-values less than
4 correlates with the severity of GERD
[26]. The extreme in the relationship
between acid output and GERD is exem-
plified by patients with Zollinger-Ellison
syndrome who tend to suffer from erosive
esophagitis [22]. Lastly, the protective
influence ofcorpus gastritis against GERD
also points at the essential role of acid in
GERD. On the other hand, Hirschowitz
has shown in multiple, well-designed stud-
ies that the amount of gastric acid output
does not correlate with the severity of
GERD [23-24]. How can one reconcile the
seemingly contradictory findings? One
possible explanation is that gastric acidity
represents anecessary, but taken alone, not
sufficient, prerequisite for the develop-
ment of GERD. Other mechanisms would
determine how much of the available acid
is capable to exert its corrosive action on
the squamous epithelium of the esopha-
gus. The factors that influence the severity
of reflux disease have remained mysteri-
ous. What determines whether GERD in
an individual patient will be characterized
by erosions or symptoms only? Why do
some patients develop esophageal ulcers,
strictures and Barrett's mucosa, while oth-
ers with similar amounts of gastroe-
sophageal reflux do not develop even the
slightest break of their esophageal
mucosa?
The normal-appearing gastroe-
sophageal junction can harbor intestinal
metaplasia in 18 percent to 36 percent of
patients with symptoms of gastroe-
sophageal reflux [45-46]. It appears that
both reflux of gastric contents and H.
pylori infection of the cardia can result in
intestinal metaplasia at the gastroe-
sophageal junction. Only intestinal meta-
plasia associated with reflux, however,
seems capable of promoting cardiac can-
cer, as evidenced by the opposing time
trends of cardiac versus body or antral
cancerofthe stomach. What are character-
istics that render one type of intestinal
metaplasia particularly prone to malignant
transformation?
It seems that the discovery of H.
pylori has not only furthered our concepts
regarding peptic ulcer and gastric cancer,
but also that in the near future it will also
help resolve some of the enigmas sur-
rounding GERD. The potential role of H.
pylori infection in the pathogenesis GERD
gives the opportunity to develop interest-
ing hypotheses and design new epidemio-
logic studies. These studies will deepen
our understanding ofGERD.90 Sonnenberg and El-Serag: GERD Epidemiology
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